March 2014 Issue
Pharmaceutical manufacturing capacity is increasingly global and going biologic, but challenged to meet the realities of cGMP
PhM’s 2014 Reader Survey reveals respondents are recognizing relative stability amidst ever-present change and challenging market conditions
Three unique examples of single-use solutions that saved time and money and enabled growth.
Imagine a world where all key stakeholders have supply chain visibility
Powerful MVA and DoE methods are giving biotech companies greater insights from complex data
New pharmaceutical packages not only protect proteins, but also prevent counterfeiting
Dynamic powder testing in process assures critical quality attributes of tablets
Manufacturing pharmaceuticals is not for the faint of heart, no matter where you’re from
Continuous manufacturing’s rising star has process analytical technologies at its heart.
As the lines between healthcare, technology and pharma continue to blur, pharma finds itself with more opportunity than ever before.